Extract

The purpose of this clinical research study is to learn if human immunodeficiency virus (HIV)-infected subjects with abdominal fat accumulation on their highly active antiretroviral treatment (HAART) regimen have better changes in fat distribution after switching to atazanavir-ritonavir than those remaining on their current protease inhibitor boosted HAART regimen.

Inclusion criteria

• HIV-Associated Lipodystrophy Syndrome

Country

• Canada
• France
• Germany
• Italy
• Mexico
• Poland
• Spain
• United Kingdom
• United States

Links

• nct
• ictrp